Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Independent Authority Certifies that Palo Alto Networks Traps Helps Customers Meet PCI and HIPAA Cybersecurity Requirements

Palo Alto Networks
Posted on: 04 Oct 16

PR Newswire

SANTA CLARA, Calif., Oct. 4, 2016

SANTA CLARA, Calif., Oct. 4, 2016 /PRNewswire/ -- Palo Alto Networks® (NYSE: PANW), the next-generation security company, today announced that customers implenting its Traps™ advanced endpoint protection offering will meet specific cybersecurity requirements outlined by both the Health Insurance Portability and Accountability Act (HIPAA) and the Payment Card Industry (PCI) Data Security Standard.

Independent analysis completed by Coalfire Systems, a respected leader in cyber risk management and compliance services and a Qualified Security Assessor (QSA), concludes that organizations in the financial and healthcare sectors can replace legacy antivirus endpoint products with Traps to help prevent cyber breaches while remaining compliant with federal law and industry standards.


  • "Traps uses a unique multi-method approach to prevent cyber breaches, advanced malware, and zero-day exploits to effectively secure endpoints without reliance on static signatures or the need to immediately apply security patches across an organization. These advanced endpoint protection capabilities, along with verified certification from a trusted QSA to meet both PCI DSS and HIPAA security compliance standards, will make the decision to replace legacy AV products with Traps a much easier one for our healthcare and financial services customers."
    -          Dal Gemmell, head of Traps marketing, Palo Alto Networks

An alternative to legacy antivirus point products, Traps uniquely combines the most effective, purpose-built malware and exploit detection methods to prevent known and unknown threats before they can successfully compromise an endpoint. It is a key component of the Palo Alto Networks Next-Generation Security Platform, a natively integrated platform that safely enables applications and delivers highly automated, preventive protection against cyberthreats at all stages in the attack lifecycle.

Coalfire's assessment of Traps was reached after completing technical testing; review of the overall design, architecture and supporting documentation; and interviews with subject matter experts.

Coalfire Labs assessments confirmed that Traps enables organizations to either achieve or remain compliant with HIPAA's technical requirements related to security as outlined in the HIPAA Security Rule and with version 3.2 of the PCI DSS.

To download the full Coalfire reports, visit:

To learn more about Palo Alto Networks offerings, visit:

About Palo Alto Networks

Palo Alto Networks is the next-generation security company, leading a new era in cybersecurity by safely enabling applications and preventing cyber breaches for tens of thousands of organizations worldwide. Built with an innovative approach and highly differentiated cyberthreat prevention capabilities, our game-changing security platform delivers security far superior to legacy or point products, safely enables daily business operations, and protects an organization's most valuable assets. Find out more at

Palo Alto Networks and the Palo Alto Networks logo are trademarks of Palo Alto Networks, Inc. in the United States and in jurisdictions throughout the world. All other trademarks, trade names or service marks used or mentioned herein belong to their respective owners.

Logo -

To view the original version on PR Newswire, visit:

SOURCE Palo Alto Networks

PR Newswire

Last updated on: 04/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.